Sunday, July 5, 2015

Are you my partner or competitor: AmerisourceBergen-Walgreens deal another big change in drug market

The way healthcare and medicine is made and delivered has changed quickly in the last few years and Tuesday's announcement of a collaboration between wholesaler AmerisourceBergen and retail pharmacy giant Walgreens adds another element.

Are you my partner or competitor: AmerisourceBergen-Walgreens deal another big change in drug market

0 comments

You are my partner. You are my competitor.

The way healthcare and medicine is made and delivered has changed quickly in the last few years and Tuesday's announcement of a collaboration between wholesaler AmerisourceBergen and retail pharmacy giant Walgreens adds another element.

Doctors have sold practices to join hospital companies.

Brand-name drug companies have added generic elements and vice versa.

Retail drug stores have become pharmacy benefit managers.

Hospitals have become insurers.

AmerisourceBergen's headquarters is in Chesterbrook and it employs about 1100 people locally.

The agreement with Walgreens and Alliance Boots GmbH will create a vehicle for all of them to pressure drugmakers to reduce prices if they want those entities to transfer their drugs to patients.

ExpressScripts, which is the biggest pharmacy benefits manager, was AmerisourceBergen's biggest customer and AmerisourceBergen has a collaboration with independent neighborhood pharmacies.

The discussions with all of those groups will be a bit more complex.

AmerisourceBergen's SEC filing on the Walgreens deal is here.

 

 

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter